एपीए उद्धरण

Kim, S. T., Oh, S. Y., Lee, J., Kang, J. H., Lee, H. W., Lee, M. A., . . . Lim, H. Y. (2019). Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial. J Cancer.

शिकागो स्टाइल उद्धरण

Kim, Seung Tae, et al. "Capecitabine Plus Oxaliplatin As a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial." J Cancer 2019.

एमएलए उद्धरण

Kim, Seung Tae, et al. "Capecitabine Plus Oxaliplatin As a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial." J Cancer 2019.